Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medicago Inc MDCGF

Healthcare Biotechnology


GREY:MDCGF - Post by User

Medicago Inc > Focus on the positive Releases >>>
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by GlassHalfEmptyon Nov 02, 2010 10:07pm
252 Views
Post# 17648616

RE: Focus on the positive Releases >>>

RE: Focus on the positive Releases >>>WHY????
POSITIVE news releases result in NEGATIVE stock price
Time and time again
Because ...
Management spends too much time helping friends and insiders.
The result?
This stock may never amount to anything.
I am a typical shareholder and right now these guys have zero trust from me!
If this company is ever  going to amount to anything they have to win back my trust
And that of the hundreds of other shareholders.
Prosper together or fail
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities